02:52 PM EDT, 03/10/2025 (MT Newswires) -- BioCardia ( BCDA ) said Monday it received a Japanese patent titled "Radial and Transendocardial Delivery Catheter" for its catheter technology Helix Biotherapeutic Delivery System.

The patent, valid until on or after Sept. 30, 2034, covers catheters designed to deliver biological therapies directly to targeted areas of the heart, the company said.

The patent's claims include BioCardia's ( BCDA ) helical needle-tipped catheter technology platform, which is used in the administration of cardiac treatments, it added.

Shares of BioCardia ( BCDA ) were down 3% in recent trading.

Price: 2.54, Change: -0.08, Percent Change: -3.05